These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24565992)

  • 1. Late cardiovascular complications after hematopoietic cell transplantation.
    Chow EJ; Wong K; Lee SJ; Cushing-Haugen KL; Flowers ME; Friedman DL; Leisenring WM; Martin PJ; Mueller BA; Baker KS
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):794-800. PubMed ID: 24565992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
    Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation.
    Leger KJ; Baker KS; Cushing-Haugen KL; Flowers MED; Leisenring WM; Martin PJ; Mendoza JA; Reding KW; Syrjala KL; Lee SJ; Chow EJ
    Cancer; 2018 Apr; 124(7):1507-1515. PubMed ID: 29315507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation.
    Chow EJ; Mueller BA; Baker KS; Cushing-Haugen KL; Flowers ME; Martin PJ; Friedman DL; Lee SJ
    Ann Intern Med; 2011 Jul; 155(1):21-32. PubMed ID: 21727290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late Kidney Morbidity and Mortality in Hematopoietic Cell Transplant Survivors.
    Wu NL; Hingorani S; Cushing-Haugen KL; Lee SJ; Chow EJ
    Transplant Cell Ther; 2021 May; 27(5):434.e1-434.e6. PubMed ID: 33775588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation.
    Chow EJ; Baker KS; Lee SJ; Flowers ME; Cushing-Haugen KL; Inamoto Y; Khera N; Leisenring WM; Syrjala KL; Martin PJ
    J Clin Oncol; 2014 Jan; 32(3):191-8. PubMed ID: 24297944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors.
    Chow EJ; Cushing-Haugen KL; Cheng GS; Boeckh M; Khera N; Lee SJ; Leisenring WM; Martin PJ; Mueller BA; Schwartz SM; Baker KS
    J Clin Oncol; 2017 Jan; 35(3):306-313. PubMed ID: 27870568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
    Fulcher J; Blanchard AP; Bredeson C; van Walraven C
    Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation.
    Armenian SH; Sun CL; Mills G; Teh JB; Francisco L; Durand JB; Wong FL; Forman SJ; Bhatia S
    Biol Blood Marrow Transplant; 2010 Aug; 16(8):1138-44. PubMed ID: 20197101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
    Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.
    Armenian SH; Sun CL; Vase T; Ness KK; Blum E; Francisco L; Venkataraman K; Samoa R; Wong FL; Forman SJ; Bhatia S
    Blood; 2012 Nov; 120(23):4505-12. PubMed ID: 23034279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study.
    Arora M; Sun CL; Ness KK; Teh JB; Wu J; Francisco L; Armenian SH; Schad A; Namdar G; Bosworth A; Kuo L; Weisdorf DJ; Forman SJ; Bhatia S
    JAMA Oncol; 2016 Oct; 2(10):1277-1286. PubMed ID: 27254472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation.
    Baker KS; Chow E; Steinberger J
    Bone Marrow Transplant; 2012 May; 47(5):619-25. PubMed ID: 21643022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation Survivors.
    Leger KJ; Cushing-Haugen K; Hansen JA; Fan W; Leisenring WM; Martin PJ; Zhao LP; Chow EJ
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1094-1101. PubMed ID: 26968791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.
    Friedman DN; Hilden P; Moskowitz CS; Suzuki M; Boulad F; Kernan NA; Wolden SL; Oeffinger KC; Sklar CA
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):475-482. PubMed ID: 28040534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.
    Goldman JM; Majhail NS; Klein JP; Wang Z; Sobocinski KA; Arora M; Horowitz MM; Rizzo JD
    J Clin Oncol; 2010 Apr; 28(11):1888-95. PubMed ID: 20212247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report.
    Armenian SH; Chemaitilly W; Chen M; Chow EJ; Duncan CN; Jones LW; Pulsipher MA; Remaley AT; Rovo A; Salooja N; Battiwalla M
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):201-210. PubMed ID: 27590105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
    Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.